MICHAEL RAAB Insider Trading $FOLD AMICUS THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL RAAB.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL RAAB. MICHAEL RAAB is Director in AMICUS THERAPEUTICS INC ($FOLD) and President & CEO in ARDELYX, INC. ($ARDX).
MICHAEL RAAB in AMICUS THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL RAAB: Director
Holdings: 21,000 shares
Current Value: $126,420
Latest Transaction: Jun 08 2020
$FOLD Market Capitalization: $869.61M
$FOLD Previous Close: $6.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL RAAB in AMICUS THERAPEUTICS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 08 2020 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 12.81 | 18,574 | 237,933 | 18,574 | |
| Jun 08 2020 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Grant | A | 0.00 | 5,855 | 0 | 21,000 | 15.1 K to 21 K (+38.66 %) |
| Jun 03 2020 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 2.81 | 5,000 | 14,050 | 0 | |
| Jun 03 2020 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Sell | S | 12.65 | 5,000 | 63,261 | 15,145 | 20.1 K to 15.1 K (-24.82 %) |
| Jun 03 2020 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Buy | M | 2.81 | 5,000 | 14,050 | 20,145 | 15.1 K to 20.1 K (+33.01 %) |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 12.00 | 19,473 | 233,676 | 19,473 | |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Grant | A | 0.00 | 6,250 | 0 | 15,145 | 8.9 K to 15.1 K (+70.26 %) |
| Jun 04 2019 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 7.15 | 5,000 | 35,750 | 0 | |
| Jun 04 2019 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Sell | S | 11.16 | 5,000 | 55,776 | 8,895 | 13.9 K to 8.9 K (-35.98 %) |
| Jun 04 2019 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Buy | M | 7.15 | 5,000 | 35,750 | 13,895 | 8.9 K to 13.9 K (+56.21 %) |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 16.23 | 8,912 | 144,642 | 8,912 | |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Grant | A | 0.00 | 3,081 | 0 | 8,895 | 5.8 K to 8.9 K (+52.99 %) |
| Apr 18 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 10.53 | 5,000 | 52,650 | 0 | |
| Apr 18 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Sell | S | 14.41 | 5,000 | 72,058 | 5,814 | 10.8 K to 5.8 K (-46.24 %) |
| Apr 18 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Buy | M | 10.53 | 5,000 | 52,650 | 10,814 | 5.8 K to 10.8 K (+86.00 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 7.51 | 4,366 | 32,789 | 5,634 | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 2.81 | 5,000 | 14,050 | 5,000 | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Sell | S | 15.00 | 9,366 | 140,490 | 5,814 | 15.2 K to 5.8 K (-61.70 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Buy | M | 15.00 | 9,366 | 140,490 | 15,180 | 5.8 K to 15.2 K (+161.09 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 7.15 | 5,000 | 35,750 | 5,000 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 10.53 | 5,000 | 52,650 | 5,000 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Sell | S | 14.25 | 10,000 | 142,534 | 5,814 | 15.8 K to 5.8 K (-63.24 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Buy | M | 14.25 | 10,000 | 142,534 | 15,814 | 5.8 K to 15.8 K (+172.00 %) |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 8.60 | 16,236 | 139,630 | 16,236 | |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Grant | A | 0.00 | 5,814 | 0 | 5,814 | 0 to 5.8 K |
| Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 6.71 | 20,000 | 134,200 | 20,000 | |
| Jun 12 2015 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 13.09 | 20,000 | 261,800 | 20,000 | |
| Jun 09 2015 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Sell | D | 12.65 | 8,936 | 113,040 | 0 | 8.9 K to 0 (-100.00 %) |
Page: 1